Immunologic and rheumatologic causes and treatment of recurrent pregnancy loss: what is the evidence?

Fertile Battle

Editorial Office, American Society for Reproductive Medicine

Published Dec 15, 2019

Volume 112, Issue 6, Pages 1002–1012

Authors:

Joshua Odendaal, M.B.B.S., B.Sc., Siobhan Quenby, M.D., Lisa Sammaritano, M.D., Nick Macklon, M.D., Ph.D., D. Ware Branch, M.D., Zev Rosenwaks, M.D.

Abstract:

PRO: There is sufficient evidence to support treating immunologic aspects of recurrent pregnancy loss.

CON: There is insufficient evidence to support treating immunologic aspects of recurrent pregnancy loss.

Read the full text here.

There is sufficient evidence to support treating immunologic RPL

Agree

Disagree

Created with Poll Maker

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.

Immunologic and rheumatologic causes and treatment of recurrent pregnancy loss: what is the evidence?

Share

Volume 112, Issue 6, Pages 1002–1012

Authors:

Abstract:

Fertility and Sterility

You may also be interested in...

Should women undergoing in vitro fertilization treatment or who are in the first trimester of pregnancy be vaccinated immediately against COVID-19

Reproductive Endocrinology and Infertility fellowship programs: Does one size fit all?

Should couples with unexplained infertility have three to six cycles of intrauterine insemination with ovarian stimulation or in vitro fertilization as first-line treatment?

Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons